title: [Establishment of the retrovirus-mediated murine model with MLL-AF9 leukemia].
abstract: This study was purposed to establish a retrovirus-mediated murine model with MLL-AF9 leukemia, so as to provide a basis for further investigation of the pathogenesis and therapeutic strategy of MLL associated leukemia. Murine (CD45.2) primary hematopoietic precursor positively selected for expression of the progenitor marker c-Kit by means of MACS were transduced with a retrovirus carrying MLL-AF9 fusion gene. After cultured in vitro, the transduced cells were injected intravenously through the tail vein into the lethally irradiated mice (CD45.1). PCR, flow cytometry and morphological observation were employed to evaluate the murine leukemia model system. The results showed that MLL-AF9 fusion gene was expressed in the infected cells, and the cells had a dramatically enhanced potential to generate myeloid colonies with primitive and immature morphology. Flow cytometric analysis revealed that the immortalized cells highly expressed myeloid lineage surface markers Gr-1 and Mac-1. Moreover, the expression levels of Hoxa9 and Meis1 mRNA were significantly higher in the MLL-AF9 cells than that in control. The mice transplanted with MLL-AF9 cells displayed typical signs of leukemia within 6-12 weeks. Extensive infiltration leukemic cells was observed in the Wright-Giemsa stained peripheral blood smear and bone marrow, and also in the histology of liver and spleen. Flow cytometric analysis of the bone marrow and spleen cells demonstrated that the CD45.2 populations expressed highly myeloid markers Gr-1 and Mac-1. The leukemic mice died within 12 weeks. It is concluded that the retrovirus-mediated murine model with MLL-AF9 leukemia is successfully established, which can be applied in the subsequent researches.
authors.affiliation: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
authors.forename: Si-Miao
authors.initials: SM
authors.lastname: Xu
authors.forename: Yang
authors.initials: Y
authors.lastname: Yang
authors.forename: Mi
authors.initials: M
authors.lastname: Zhou
authors.forename: Xue-Jiao
authors.initials: XJ
authors.lastname: Zhao
authors.forename: Yu
authors.initials: Y
authors.lastname: Qin
authors.forename: Pei-Ling
authors.initials: PL
authors.lastname: Zhang
authors.forename: Rui-Feng
authors.initials: RF
authors.lastname: Yuan
authors.forename: Jian-Feng
authors.initials: JF
authors.lastname: Zhou
authors.forename: Yong
authors.initials: Y
authors.lastname: Fang
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D015456:Leukemia, Biphenotypic, Acute; D051379:Mice; D008810:Mice, Inbred C57BL; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D012190:Retroviridae / Q000235:genetics*; D014162:Transfection
chemical_list: C551356:MLL-AF9 fusion protein, mouse; D015514:Oncogene Proteins, Fusion